Table 2.
Indices | Phase | Betamethasone | Olivederma | p-value* |
---|---|---|---|---|
SCORAD- A | Baseline | 44.4 ± 8.7 | 75.1 ± 7.2 | < 0.001 |
6th week | 35.5 ± 9.9 | 23.3 ± 13.6 | ||
p-value# | 0.006 | < 0.001 | ||
SCORAD- B | Baseline | 9.6 ± 1.5 | 9.4 ± 1.7 | < 0.001 |
6th week | 8.1 ± 2.3 | 3.2 ± 1.8 | ||
p-value# | 0.004 | < 0.001 | ||
SCORAD- C | Baseline | 15.8 ± 2.7 | 19.5 ± 0.9 | < 0.001 |
6th week | 15.2 ± 3.4 | 8.2 ± 5.7 | ||
p-value# | 0.545 | < 0.001 | ||
SCORAD total | Baseline | 58.4 ± 7.3 | 67.3 ± 6.3 | < 0.001 |
6th week | 50.5 ± 10.7 | 23.9 ± 13.3 | ||
p-value# | 0.003 | < 0.001 |
#Within-group (time effect) significance.
*Between-group (intervention * time effect) significance.